Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Laetsch TW, Maude SL, Rives S, Hiramatsu H, Bittencourt H, Bader P, Baruchel A, Boyer M, De Moerloose B, Qayed M, Buechner J, Pulsipher MA, Myers GD, Stefanski HE, Martin PL, Nemecek E, Peters C, Yanik G, Khaw SL, Davis KL, Krueger J, Balduzzi A, Boissel N, Tiwari R, O'Donovan D, Grupp SA. Laetsch TW, et al. Among authors: hiramatsu h. J Clin Oncol. 2023 Mar 20;41(9):1664-1669. doi: 10.1200/JCO.22.00642. Epub 2022 Nov 18. J Clin Oncol. 2023. PMID: 36399695 Free PMC article. Clinical Trial.
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.
Miyagawa N, Goto H, Ogawa A, Kikuta A, Kosaka Y, Sekimizu M, Tomizawa D, Toyoda H, Hiramatsu H, Hara J, Mochizuki S, Nakayama H, Yoshimura K, Iijima-Yamashita Y, Sanada M, Ogawa C. Miyagawa N, et al. Among authors: hiramatsu h. Int J Hematol. 2023 Aug;118(2):267-276. doi: 10.1007/s12185-023-03609-8. Epub 2023 May 1. Int J Hematol. 2023. PMID: 37127801 Clinical Trial.
Outcome and growth of lobar graft after pediatric living-donor lobar lung transplantation.
Tanaka S, Nakajima D, Sakamoto R, Oguma T, Kawaguchi A, Ohsumi A, Ohata K, Ueda S, Yamagishi H, Kayawake H, Yutaka Y, Yamada Y, Hamaji M, Hamada S, Tanizawa K, Handa T, Suga T, Baba S, Hiramatsu H, Ikeda T, Date H. Tanaka S, et al. Among authors: hiramatsu h. J Heart Lung Transplant. 2023 May;42(5):660-668. doi: 10.1016/j.healun.2022.12.010. Epub 2022 Dec 15. J Heart Lung Transplant. 2023. PMID: 36585287
Theoretical and data-driven approaches to semiconductors and dielectrics: from prediction to experiment.
Oba F, Nagai T, Katsube R, Mochizuki Y, Tsuji M, Deffrennes G, Hanzawa K, Nakano A, Takahashi A, Terayama K, Tamura R, Hiramatsu H, Nose Y, Taniguchi H. Oba F, et al. Among authors: hiramatsu h. Sci Technol Adv Mater. 2024 Nov 4;25(1):2423600. doi: 10.1080/14686996.2024.2423600. eCollection 2024. Sci Technol Adv Mater. 2024. PMID: 39687423 Free PMC article. Review.
Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan.
Kato I, Tomizawa D, Kato M, Hirabayashi S, Manabe A, Irie M, Sasahara Y, Arakawa Y, Koh K, Sakaguchi H, Sugiyama M, Ogawa C, Kamiya T, Saito S, Nakazawa Y, Nishio N, Takahashi Y, Iwai N, Adachi S, Takita J, Miyamura T, Yokoyama S, Oba U, Ueda T, Koga Y, Hiramatsu H. Kato I, et al. Among authors: hiramatsu h. Transplant Cell Ther. 2024 Nov 30:S2666-6367(24)00799-1. doi: 10.1016/j.jtct.2024.11.016. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39617098 Free article.
Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Kato S, Tsujimoto SI, Matsubayashi J, Iwamoto S, Hiramatsu H, Okuno Y, Kamitori T, Ohki K, Deguchi T, Kiyokawa N, Kato M, Takita J, Tanaka S, Adachi S, Tomizawa D, Shiba N. Kato S, et al. Among authors: hiramatsu h. Haematologica. 2024 Sep 5. doi: 10.3324/haematol.2024.286243. Online ahead of print. Haematologica. 2024. PMID: 39234860 Free article.
MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.
Uchihara Y, Umeda K, Yamada Y, Ito H, Tasaka K, Isobe K, Akazawa R, Kawabata N, Saida S, Kato I, Hiramatsu H, Noguchi T, Sakamoto A, Arakawa Y, Arakawa A, Yamamoto N, Hosoya Y, Uemura S, Watanabe KI, Sano H, Taga T, Takita J. Uchihara Y, et al. Among authors: hiramatsu h. Cancer Sci. 2024 Oct;115(10):3394-3402. doi: 10.1111/cas.16297. Epub 2024 Jul 30. Cancer Sci. 2024. PMID: 39080996 Free PMC article.
Quadrupling the depairing current density in the iron-based superconductor SmFeAsO1-xHx.
Miura M, Eley S, Iida K, Hanzawa K, Matsumoto J, Hiramatsu H, Ogimoto Y, Suzuki T, Kobayashi T, Ozaki T, Kurokawa H, Sekiya N, Yoshida R, Kato T, Okada T, Okazaki H, Yamaki T, Hänisch J, Awaji S, Maeda A, Maiorov B, Hosono H. Miura M, et al. Among authors: hiramatsu h. Nat Mater. 2024 Oct;23(10):1370-1378. doi: 10.1038/s41563-024-01952-7. Epub 2024 Jul 18. Nat Mater. 2024. PMID: 39026087 Free PMC article.
428 results